05/29/2026
The federal government recently extended the pandemic-era telemedicine prescribing flexibilities through the end of 2026. But the extension did not answer the bigger question: what happens after that?
Psychiatrists across the field are still trying to read between the lines on what the DEA and the federal government actually intend to do long-term.
This clip from our latest episode of The Telepsychiatry Advantage, where Dr. Edward Kaftarian walks through what he believes the extension may really be signaling. You can listen to the full episode below!
Apple Podcasts: https://podcasts.apple.com/us/podcast/the-telepsychiatry-advantage/id1893377031
Spotify: https://open.spotify.com/show/1sk8JaIhTzOQe9qlAQQPid?si=0b6fd812955c46f9
YouTube: https://youtu.be/-Uz6QWTxo2k